Light Chain Bioscience successfully completes Factor VIII mimetic bispecific antibody discovery for Takeda.
NovImmune SA is excited to be launching today the all new company website and branding.
Light Chain Bioscience successfully completes Factor VIII mimetic bispecific antibody discovery for Takeda.
NovImmune SA is excited to be launching today the all new company website and branding.
